2,4-dinitrobenzenesulfonic acid has been researched along with Chronic Illness in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cook, GA; Giraud, AS; Thim, L; Tran, CP; Yeomans, ND | 1 |
| Chain, F; Cherbuy, C; Escribano-Vazquez, U; Langella, P; Martin, R; Thomas, M; Verstraeten, S | 1 |
2 other study(ies) available for 2,4-dinitrobenzenesulfonic acid and Chronic Illness
| Article | Year |
|---|---|
Trefoil peptide TFF2 (spasmolytic polypeptide) potently accelerates healing and reduces inflammation in a rat model of colitis.
Topics: Administration, Rectal; Animals; Benzenesulfonates; Chronic Disease; Colitis; Disease Models, Animal; Ethanol; Growth Substances; Humans; Male; Mucins; Muscle Proteins; Neuropeptides; Peptides; Peroxidase; Rats; Rats, Wistar; Recombinant Proteins; Trefoil Factor-2; Trefoil Factor-3 | 1999 |
The commensal Escherichia coli CEC15 reinforces intestinal defences in gnotobiotic mice and is protective in a chronic colitis mouse model.
Topics: Animals; Benzenesulfonates; Chronic Disease; Colitis; Colon; Disease Models, Animal; Escherichia coli; Gastrointestinal Microbiome; Gene Expression Regulation; Germ-Free Life; Host Microbial Interactions; Humans; Interleukin-10; Intestinal Mucosa; Male; Mice; Severity of Illness Index; Symbiosis | 2019 |